Mary Carrington | Academic Influence

Mary Carrington's AcademicInfluence.com Rankings

Mary Carrington

Biology

#5591

World Rank

#8106

Historical Rank

Immunology

#321

World Rank

#334

Historical Rank

biology Degrees

Download Badge

Biology

Mary Carrington's Degrees

Bachelors Biology University of California, Berkeley
PhD Immunology Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Mary Carrington Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mary N. Carrington is an American immunologist researching the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis. She is director of the basic science program at the Frederick National Laboratory for Cancer Research.

(See a Problem?)

Mary Carrington's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene (1996) (2691)
Interleukin-1 polymorphisms associated with increased risk of gastric cancer (2000) (2424)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus (2009) (2197)
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. (1999) (1317)
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS (2002) (1231)
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection (2004) (1202)
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation (2010) (1129)
Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success (2004) (1039)
Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection (1996) (1033)
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. (1997) (963)
The influence of HLA genotype on AIDS. (2003) (827)
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC (2006) (764)
Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) (1998) (761)
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 (2007) (746)
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. (2011) (675)
Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 (2009) (526)
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. (2001) (520)
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. (1998) (490)
Genetic acceleration of AIDS progression by a promoter variant of CCR5. (1998) (483)
Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes (2007) (464)
Common Genetic Variation and the Control of HIV-1 in Humans (2009) (448)
Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. (2010) (440)
The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans (2011) (432)
Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1 (2002) (362)
A Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin (Dc-Sign)–Related Protein Is Highly Expressed on Human Liver Sinusoidal Endothelial Cells and Promotes HIV-1 Infection (2001) (358)
The Yin and Yang of HLA and KIR in human disease. (2008) (355)
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 (2006) (345)
Influence of HLA-C Expression Level on HIV Control (2013) (343)
HIV-1 adaptation to NK cell mediated immune pressure (2011) (337)
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. (1999) (324)
Differential microRNA regulation of HLA-C expression and its association with HIV control (2011) (319)
Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. (2008) (301)
Effects of thymic selection of the T cell repertoire on HLA-class I associated control of HIV infection (2010) (296)
Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication (2007) (295)
The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication (2006) (288)
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C (2009) (283)
Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis1 (2004) (279)
Timing of the Last Glacial Maximum from observed sea-level minima (2001) (276)
KIR and disease: a model system or system of models? (2006) (275)
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes (2007) (269)
HIV-1 DNA predicts disease progression and post-treatment virological control (2014) (267)
The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. (2006) (265)
HIV-1 infection in a man homozygous for CCR5▵32 (1997) (258)
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes (2006) (256)
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects (2013) (252)
Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B12 (2007) (251)
High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis (2014) (250)
Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. (1999) (244)
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci (2005) (243)
DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells (2003) (241)
Global diversity and evidence for coevolution of KIR and HLA (2007) (233)
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. (2003) (230)
HLA and AIDS: a cautionary tale. (2001) (230)
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis (2005) (230)
High-resolution patterns of meiotic recombination across the human major histocompatibility complex. (2002) (227)
Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells (2009) (223)
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. (2003) (222)
Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection (2008) (202)
Racial differences in HLA class II associations with hepatitis C virus outcomes. (2001) (200)
HLA-Cw*04 and Hepatitis C Virus Persistence (2002) (200)
Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts (2013) (199)
Coordinate linkage of HIV evolution reveals regions of immunological vulnerability (2011) (199)
High HLA-DP Expression and Graft-versus-Host Disease. (2015) (195)
KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections (2006) (188)
HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection (2009) (187)
A scan for linkage disequilibrium across the human genome. (1999) (186)
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. (2013) (183)
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. (2017) (175)
An integrated haplotype map of the human major histocompatibility complex. (2003) (174)
Balanced polymorphism selected by genetic versus infectious human disease. (2003) (173)
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. (2011) (172)
Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. (2008) (168)
Host determinants of HIV-1 control in African Americans. (2010) (165)
Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 (2016) (165)
Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies (2006) (162)
Genetic Analysis of Completely Sequenced Disease-Associated MHC Haplotypes Identifies Shuffling of Segments in Recent Human History (2006) (162)
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. (1996) (161)
Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (158)
Novel alleles of the chemokine-receptor gene CCR5. (1997) (155)
KIR-HLA intercourse in HIV disease. (2008) (154)
HLA/KIR restraint of HIV: surviving the fittest. (2011) (152)
Next-generation sequencing for HLA typing of class I loci (2011) (151)
Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. (2011) (150)
Characterization of recombination in the HLA class II region. (1997) (150)
Comprehensive Analysis of Class I and Class II HLA Antigens and Chronic Hepatitis B Virus Infection (2003) (149)
Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. (2004) (146)
Unique human immune signature of Ebola virus disease in Guinea (2016) (143)
Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over 1 (2003) (142)
Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1 (2008) (141)
Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load (2015) (140)
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals (2022) (138)
Immunogenetics of HIV disease (2013) (137)
Immunogenetics of viral infections. (2005) (137)
A Novel Variant Marking HLA-DP Expression Levels Predicts Recovery from Hepatitis B Virus Infection (2012) (136)
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls (2013) (133)
The impact of host genetic variation on infection with HIV-1 (2015) (133)
The KIR Gene Cluster (2003) (132)
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus–induced microRNAs (2013) (129)
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. (2014) (128)
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. (1998) (127)
Recombination rates across the HLA complex: use of microsatellites as a rapid screen for recombinant chromosomes. (1995) (126)
Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. (2005) (126)
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 (2003) (125)
Chronic viral hepatitis and the human genome (2000) (125)
The impact of variation at the KIR gene cluster on human disease. (2006) (124)
Maternal KIR in Combination with Paternal HLA-C2 Regulate Human Birth Weight (2014) (122)
Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection (2007) (121)
Association of DC-SIGN Promoter Polymorphism with Increased Risk for Parenteral, but Not Mucosal, Acquisition of Human Immunodeficiency Virus Type 1 Infection (2004) (120)
Fine Mapping of IGAD1 in IgA Deficiency and Common Variable Immunodeficiency: Identification and Characterization of Haplotypes Shared by Affected Members of 101 Multiple-Case Families12 (2000) (120)
correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (2001) (120)
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells (2018) (119)
Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. (1995) (119)
Distinct viral reservoirs in individuals with spontaneous control of HIV-1 (2020) (116)
Class II HLA alleles and hepatitis B virus persistence in African Americans. (1999) (116)
Relative Expression Levels of the HLA Class-I Proteins in Normal and HIV-Infected Cells (2015) (114)
Enhanced Anti-HIV Functional Activity Associated with Gag-Specific CD8 T-Cell Responses (2010) (112)
CCR2 chemokine receptor and AIDS progression (1997) (112)
HIV-1 Vpu Mediates HLA-C Downregulation. (2016) (110)
Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1 (2012) (110)
Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV‐1 infection (1998) (108)
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia (2010) (107)
Recombination within the human MHC (1999) (107)
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. (2001) (107)
Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression (2007) (105)
Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 Allelic Profiles and Motifs Define Clinicopathologic Groups in Caucasians (2005) (105)
Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN (2002) (105)
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. (2010) (104)
Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy (2000) (103)
Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex (2009) (99)
Immunogenetics of spontaneous control of HIV. (2012) (98)
Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease (2013) (96)
Molecular mapping of a recombination hotspot located in the second intron of the human TAP2 locus. (1995) (96)
HIV-1 Infection in Individuals With the CCR5-Δ32/Δ32 Genotype: Acquisition of Syncytium-Inducing Virus at Seroconversion (2002) (94)
Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1 (2001) (94)
Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control (2013) (93)
The Principal Genetic Determinants for Nasopharyngeal Carcinoma in China Involve the HLA Class I Antigen Recognition Groove (2012) (92)
Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors. (2014) (92)
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. (2006) (91)
Genetic Protection against Hepatitis B Virus Conferred by CCR5Δ32: Evidence that CCR5 Contributes to Viral Persistence (2006) (91)
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. (1999) (90)
Dating the Origin of the CCR 5D 32 AIDS-Resistance Allele by the Coalescence of Haplotypes (2007) (88)
Polymorphisms of the human IFNG gene noncoding regions (2000) (86)
MHC Heterozygote Advantage in Simian Immunodeficiency Virus–Infected Mauritian Cynomolgus Macaques (2010) (85)
Phenotype Frequencies of Autosomal Minor Histocompatibility Antigens Display Significant Differences among Populations (2007) (85)
Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma (1996) (84)
Structural and regulatory diversity shape HLA-C protein expression levels (2017) (83)
Influence of CCR5 promoter haplotypes on AIDS progression in African–Americans (2000) (83)
Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. (1992) (81)
HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. (2006) (81)
Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial (2009) (79)
Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients. (1997) (79)
HLA-B*35-Px–mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses (2009) (78)
HIV Control Is Mediated in Part by CD8+ T-Cell Targeting of Specific Epitopes (2014) (78)
Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. (2007) (78)
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer (2021) (77)
Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. (2008) (77)
KIR Genotyping and Analysis (2008) (76)
p53 polymorphism and risk of cervical cancer (1998) (76)
Common HIV-1 Peptide Variants Mediate Differential Binding of KIR3DL1 to HLA-Bw4 Molecules (2011) (75)
HIV-1 infection in a man homozygous for CCR5 delta 32. (1997) (75)
Variation of the Killer Cell Immunoglobulin-Like Receptors and HLA-C Genes in Nasopharyngeal Carcinoma (2005) (74)
Innate immune control of HIV. (2012) (74)
Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. (2010) (73)
Novel KIR3DL1 Alleles and Their Expression Levels on NK Cells: Convergent Evolution of KIR3DL1 Phenotype Variation?12 (2008) (73)
Distinct Assembly Profiles of HLA-B Molecules (2014) (73)
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat (2015) (73)
The Major Histocompatibility Complex Class II Alleles Mamu-DRB1*1003 and -DRB1*0306 Are Enriched in a Cohort of Simian Immunodeficiency Virus-Infected Rhesus Macaque Elite Controllers (2007) (73)
Considering genetic profiles in functional studies of immune responsiveness to HIV-1. (2001) (72)
Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. (2013) (71)
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. (2008) (69)
KIR locus polymorphisms: genotyping and disease association analysis. (2008) (69)
KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection (2011) (69)
Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. (2002) (68)
Heterogeneity in rates of recombination in the 6-Mb region telomeric to the human major histocompatibility complex. (1997) (68)
Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection. (2003) (67)
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome (2019) (67)
A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates (2009) (67)
Epigenetic regulation of differential HLA-A allelic expression levels. (2015) (66)
Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+-T-Cell Responses for Groups of HIV-1-Infected Individuals with Different HLA-B*35 Genotypes (2002) (66)
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa (2015) (65)
Statistical Resolution of Ambiguous HLA Typing Data (2008) (64)
Identification of the ancestral killer immunoglobulin-like receptor gene in primates (2006) (63)
Methods for assessing gene content diversity of KIR with examples from a global set of populations (2008) (62)
MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies. (2005) (62)
Recombinant structures expand and contract inter and intragenic diversification at the KIR locus (2013) (62)
Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease (2012) (62)
LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection (2014) (61)
HLA-A*7401–Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703 (2011) (61)
Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers (2012) (61)
Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines. (2000) (61)
A unique viral reservoir landscape in HIV-1 elite controllers (2020) (61)
KIR genotyping by multiplex PCR-SSP. (2010) (60)
Altered distribution of mucosal NK cells during HIV infection (2011) (60)
Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection12 (2007) (58)
Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations. (2006) (57)
CCL3L1 and HIV/AIDS susceptibility (2009) (57)
KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif (2011) (57)
HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. (2002) (56)
HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. (2002) (56)
Novel Member of the CD209 (DC-SIGN) Gene Family in Primates (2003) (54)
Determinants of protection among HIV‐exposed seronegative persons: an overview. (2010) (52)
HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus Infection (2008) (52)
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. (2006) (51)
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody (2019) (50)
Concordance of human leukocyte antigen haplotype‐sharing, CD4 decline and AIDS in hemophilic siblings (1995) (50)
Host genetic variation and HIV disease: from mapping to mechanism (2017) (50)
Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection (2015) (50)
Phenotypic Expressions of CCR5-Δ32/Δ32 Homozygosity (1999) (49)
A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44 (2019) (49)
Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis. (2004) (48)
Justified chauvinism: advances in defining meiotic recombination through sperm typing. (2004) (48)
Genotypic and Functional Impact of HIV-1 Adaptation to Its Host Population during the North American Epidemic (2014) (48)
Susceptibility to Reiter's syndrome is associated with alleles of TAP genes. (1995) (47)
Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families. (1994) (47)
Human leukocyte antigen class I region single-nucleotide polymorphisms are associated with leprosy susceptibility in Vietnam and India. (2011) (47)
DQ microsatellite association studies in three ethnic groups. (1997) (47)
Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2 (2021) (46)
HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region. (2016) (46)
Influence of HLA Class I and HLA-KIR Compound Genotypes on HIV-2 Infection and Markers of Disease Progression in a Manjako Community in West Africa (2010) (46)
The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. (2011) (46)
Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population (2010) (45)
F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort (2013) (45)
Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users (2010) (45)
Immunologic profile of highly exposed yet HIV type 1-seronegative men. (2002) (45)
HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection (2010) (45)
Effects of MHC class I on HIV/SIV disease in primates. (2002) (44)
HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation (2019) (44)
HLA Class I-Mediated Control of HIV-1 in the Japanese Population, in Which the Protective HLA-B*57 and HLA-B*27 Alleles Are Absent (2012) (43)
Dominant Effects of CCR2-CCR5 Haplotypes in HIV-1 Disease Progression (2004) (43)
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. (2009) (43)
The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates (2008) (43)
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. (2013) (42)
Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. (2011) (42)
Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease (2014) (41)
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. (2003) (41)
Broadly Reactive Human CD8 T Cells that Recognize an Epitope Conserved between VZV, HSV and EBV (2014) (41)
Comparison of the rapidly evolving KIR locus in Parsis and natives of India (2008) (40)
Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03: 04 and modulate primary natural killer cell function (2014) (40)
Exploiting structural differences among heteroduplex molecules to simplify genotyping the DQA1 and DQB1 alleles in human lymphocyte typing. (1993) (39)
CCR5 promoter alleles and specific DNA binding factors. (1999) (39)
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study. (2019) (38)
Lack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive population. (2009) (38)
Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function. (2016) (38)
Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes (2004) (37)
Hardy-Weinberg testing for HLA class II (DRB1, DQA1, DQB1, and DPB1) loci in 26 human ethnic groups. (1999) (37)
Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions (2020) (37)
Peptide binding function and the paradox of HLA disease associations (1996) (37)
Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1 (2011) (37)
Taxonomic hierarchy of HLA class I allele sequences (1999) (36)
High-density map of short tandem repeats across the human major histocompatibility complex (2003) (36)
HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer (2010) (35)
Killer cell immunoglobulin–like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1 (2018) (35)
Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease. (2014) (34)
HLA tapasin independence: broader peptide repertoire and HIV control (2020) (34)
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses (2021) (34)
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles (2017) (34)
Host genetics of HIV acquisition and viral control. (2013) (34)
Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma (2010) (33)
Dendritic cell dysfunction during primary HIV-1 infection. (2011) (33)
Consistent Effects of TSG101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 (2006) (33)
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling (2016) (33)
HLA-Cw*0102-Restricted HIV-1 p24 Epitope Variants Can Modulate the Binding of the Inhibitory KIR2DL2 Receptor and Primary NK Cell Function (2012) (32)
HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells. (2017) (32)
A polymorphic dinucleotide repeat in the third intron of TAP1. (1994) (32)
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell–mediated control of HIV-1, HCV, and HTLV-1 (2018) (32)
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study (2014) (32)
HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples (2007) (32)
Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. (2009) (32)
Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. (2010) (31)
HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses (2015) (31)
Emergence of Individual HIV-Specific CD8 T Cell Responses during Primary HIV-1 Infection Can Determine Long-Term Disease Outcome (2014) (31)
Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial. (2011) (31)
A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response (2021) (30)
Drug-Susceptible HIV-1 Infection Despite Intermittent Fixed-Dose Combination Tenofovir/Emtricitabine as Prophylaxis Is Associated With Low-Level Viremia, Delayed Seroconversion, and an Attenuated Clinical Course (2008) (30)
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy. (2022) (30)
Frequent and Strong Antibody-Mediated Natural Killer Cell Activation in Response to HIV-1 Env in Individuals with Chronic HIV-1 Infection (2012) (30)
Diversity of the KIR gene cluster in an urban Brazilian population (2012) (30)
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. (2018) (30)
Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes (2017) (30)
Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair (2013) (29)
KIR haplotypes defined by segregation analysis in 59 Centre d’Etude Polymorphisme Humain (CEPH) families (2008) (29)
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study (2021) (29)
Characterization of Mycobacterium tuberculosis–Specific Cells Using MHC Class II Tetramers Reveals Phenotypic Differences Related to HIV Infection and Tuberculosis Disease (2017) (29)
Counteraction of HLA-C-Mediated Immune Control of HIV-1 by Nef (2010) (28)
HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03. (2016) (28)
Identification of Siglec-1 null individuals infected with HIV-1 (2016) (27)
Inhibitory KIR3DL1 alleles are associated with psoriasis (2016) (27)
Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct. (1996) (27)
MICA and recovery from hepatitis C virus and hepatitis B virus infections (2004) (26)
HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation. (2020) (26)
IFNL3 (IL28B) favorable genotype escapes hepatitis C virus-induced microRNAs and mRNA decay (2013) (26)
Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1 (2011) (26)
CXCR4 polymorphisms and HIV-1 pathogenesis. (1998) (26)
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation. (2020) (26)
Human leukocyte antigen class I and II haplotypes and risk of cervical cancer. (2005) (25)
Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. (2020) (25)
Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA‐A3 and A11 in vivo (2015) (25)
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa. (2009) (25)
Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma (2014) (24)
Interaction between RANTES Promoter Variant and CCR5Δ32 Favors Recovery from Hepatitis B1 (2008) (24)
Prediagnostic human T lymphotropic virus type I provirus loads were highest in Jamaican children who developed seborrheic dermatitis and severe anemia. (2004) (24)
KIR haplotypes defined by segregation analysis in 59 Centre d’Etude Polymorphisme Humain (CEPH) families (2008) (24)
Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission. (1999) (23)
Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers (2021) (23)
A method for using serum or plasma as a source of DNA for HLA typing. (1992) (23)
HLA-C downregulation by HIV-1 adapts to host HLA genotype (2018) (23)
Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin. (2007) (23)
HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype. (2006) (23)
Identification of an elaborate NK-specific system regulating HLA-C expression (2018) (22)
Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations (2009) (22)
A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation (2021) (22)
Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral Therapy (2011) (22)
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers (2019) (21)
Host Genetic and Viral Determinants of HIV-1 RNA Set Point among HIV-1 Seroconverters from Sub-Saharan Africa (2014) (21)
Host genetic determinants of HIV pathogenesis: an immunologic perspective (2008) (21)
Characterization of HLA-DMB polymorphism (2004) (21)
Posttranscriptional Regulation of HLA-A Protein Expression by Alternative Polyadenylation Signals Involving the RNA-Binding Protein Syncrip (2017) (21)
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals (2022) (21)
HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer+ Gag-Specific CD4+ T Cells in Chronic Clade C HIV-1 Infection (2017) (21)
HLA-C levels impact natural killer cell subset distribution and function. (2016) (20)
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. (2011) (20)
CCR5-Δ32 gene deletion in HIV-1 infected patients (1997) (20)
Characterization of 12 microsatellite loci of the human MHC in a panel of reference cell lines (1997) (20)
CCR-5 genotype and sexual transmission of HIV-1. (1998) (20)
HIV peptidome-wide association study reveals patient-specific epitope repertoires associated with HIV control (2018) (19)
Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates (2019) (19)
Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503 (2009) (19)
The use of DNA heteroduplex patterns to map recombination within the HLA class II region. (1991) (19)
Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller (2017) (19)
HLA phenotype is a factor in determining rate of disease progression and outcome in HIV-1-infected individuals. (1992) (18)
Resistance to HIV infection may be genetically mediated. (1996) (18)
Risk of human T‐lymphotropic virus type I‐associated diseases in Jamaica with common HLA types (2007) (18)
Characterization of 12 microsatellite loci of the human MHC in a panel of reference cell lines (1997) (18)
HIV-1 Transmission by Dendritic Cell-specific ICAM-3-grabbing Nonintegrin (DC-SIGN) Is Regulated by Determinants in the Carbohydrate Recognition Domain That Are Absent in Liver/Lymph Node-SIGN (L-SIGN)* (2009) (17)
Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations (2010) (17)
A mutation in KIR3DS1 that results in truncation and lack of cell surface expression (2007) (17)
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries (2022) (17)
Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. (2002) (17)
HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A. (2014) (17)
SARS-CoV-2 epitope-specific CD4+ memory T cell responses across COVID-19 disease severity and antibody durability (2022) (16)
HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E (2017) (16)
SARS-CoV-2 epitope-specific CD4+ memory T cell responses across COVID-19 disease severity and antibody durability (2022) (16)
Early immune adaptation in HIV-1 revealed by population-level approaches (2014) (16)
Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression (2014) (15)
Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection (2017) (15)
Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection (2013) (15)
Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study. (2016) (15)
Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. (2006) (14)
ART reduces T cell activation and immune exhaustion markers in HIV controllers. (2019) (14)
HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection (2017) (14)
Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis (2018) (14)
Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5 (2005) (14)
Erratum: Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2 (Journal of Clinical Investigation (2010) 120, 11 (4102-4110) DOI: 10.1172/JCI43998) (2011) (14)
Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission. (2010) (14)
Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han (2019) (13)
1,25-Dihydroxyvitamin D3 decreases expression of HLA class II molecules in a melanoma cell line. (1988) (13)
HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults (2015) (13)
Selective downregulation of HLA‐C and HLA‐E in childhood acute lymphoblastic leukaemia (2016) (13)
Phenotypic expressions of CCR5-delta32/delta32 homozygosity. (1999) (13)
Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic (2015) (13)
Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia. (2020) (13)
Relation of HLA Class I and II Supertypes with Spontaneous Clearance of Hepatitis C Virus (2013) (13)
Characterization of rhesus macaque natural killer activity against a rhesus-derived target cell line at the single-cell level. (2004) (13)
Human Immunodeficiency Virus Type 1-Specific CD 8 T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD 4 T Cells † (2009) (13)
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity (2018) (12)
Genetic diversity affects the nanoscale membrane organization and signaling of natural killer cell receptors (2019) (12)
Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2 (2020) (12)
Faculty Opinions recommendation of Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. (2006) (12)
Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica. (2002) (11)
A high-resolution HLA reference panel capturing global population diversity enables multi-ethnic fine-mapping in HIV host response (2020) (11)
Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon (2007) (11)
Sequence analysis of two novel HLA-DMA alleles (1994) (11)
Class I and class II MHC bind self peptide sets that are strikingly different in their evolutionary characteristics (2000) (11)
The High-Frequency Major Histocompatibility Complex (MHC) Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication (2006) (11)
MHC recombinant families (1997) (10)
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. (2022) (10)
On stand by: host genetics of HIV control. (2013) (10)
The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies. (2006) (10)
Participants in HIV Study: Correction. (1996) (10)
CD 4 + T cells from elite controllers resist HIV-1 infection by selective upregulation of p 21 (2018) (9)
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2 (2021) (9)
Analysis of Binding of KIR 3 DS 1 * 014 to HLA Suggests Distinct Evolutionary History of KIR 3 DS 1 (2011) (9)
Faculty Opinions recommendation of Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. (2002) (9)
Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection (2012) (9)
Host factors associated with outcome from primary human immunodeficiency virus-1 infection (2008) (9)
Erratum: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (Nature (2000) 404 (398-402)) (2001) (9)
Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians (2021) (9)
Lack of Associations Between HLA Class II Alleles and Resistance to HIV-1 Infection Among White, Non-Hispanic Homosexual Men (2004) (9)
Relationship between human leukocyte antigen alleles and risk of Kaposi’s sarcoma in Cameroon (2019) (9)
A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. (2009) (9)
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption (2017) (8)
Review article: HCV ? STAT-C era of therapy (2010) (8)
Three HLA-DMB variants in Korean patients with autoimmune diseases. (1996) (8)
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection (2017) (8)
CCR5-delta 32 gene deletion in HIV-1 infected patients. (1997) (8)
LILRB 2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection (2014) (8)
Natural killer cells and HIV-1 disease (2006) (8)
A vision of KIR variation at super resolution (2016) (8)
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic (2021) (8)
Cystic fibrosis-related diabetes is associated with HLADQB1 alleles encoding Asp-57− molecules (1994) (8)
Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial (2012) (7)
13th IHWS Shared Resources Joint Report. IHWG Cell and Gene Bank and reference cell panels. (2006) (7)
Human Natural Killer Cell Receptors (2006) (7)
Letter in response to article by Saito et al. (2006) (7)
Killer cell immunoglobulin – like receptor 3 DL 1 variation modifies HLA-B * 57 protection against HIV-1 (2018) (7)
Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa. (2018) (7)
Evidence for methylation as a regulatory mechanism in HLA-DRx gene expression (2004) (7)
Tuning of NK-Specific HLA-C Expression by Alternative mRNA Splicing (2020) (7)
Topological perspective on HIV escape (2019) (6)
Pemphigus is associated withKIR 3 DL 2 expression levels and provides evidence that KIR 3 DL 2 may bind HLA A 3 and A 11 in vivo (2016) (6)
HLA Alleles B*53:01 and C*06:02 Are Associated With Higher Risk of P. falciparum Parasitemia in a Cohort in Uganda (2021) (6)
Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors (2021) (6)
HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV (2021) (6)
Robust computational design and evaluation of peptide vaccines for cellular immunity with application to SARS-CoV-2 (2020) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Differential expression of the HLA-DR genes in various melanoma cell lines treated with interferon-γ: Methylation of the HLA-DRα gene in these lines is not correlated with its expression (1987) (5)
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda (2021) (5)
HLA zygosity increases risk of hepatitis B virus-associated hepatocellular carcinoma. (2021) (5)
Hardy-Weinberg testing for HLA class II (1999) (5)
Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela. (2010) (5)
Response to Comment on “Influence of HLA-C Expression Level on HIV Control” (2013) (5)
Killer cell immunoglobulin-like receptors are associated with common variable immune deficiency pathogenesis. (2016) (5)
Erratum: Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 (Human Immunology (2003) 64 (648)) (2003) (4)
Antibodies to varicella-zoster virus in blood donors with genetic variance in CC chemokine receptor 5 (2002) (4)
Association of Inhibitory Killer Cell Immunoglobulin-like Receptor Ligands With Higher Plasmodium falciparum Parasite Prevalence (2020) (4)
The Interaction of LILRB2 with HLA-B is Associated with Psoriasis Susceptibility (2019) (4)
The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men'. (2006) (4)
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy (2022) (4)
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults (2021) (4)
A mutation in KIR3DS1 that results in truncation and lack of cell surface expression (2007) (4)
Correction: Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (4)
7th drug hypersensitivity meeting: part one (2016) (4)
A Dendritic Cell–speciﬁc Intercellular Adhesion Molecule 3–grabbing Nonintegrin (DC-SIGN)–related Protein Is Highly Expressed on Human Liver Sinusoidal Endothelial Cells and Promotes HIV-1 Infection (2001) (4)
13th IHWS NK/KIR Joint Report. Killer immunoglobulin-like receptor genotypes, haplotypes and haplotype segregation patterns evaluated in the workshop KIR reference DNA panel. (2006) (4)
Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1. (2022) (3)
Localization of the recombination points in a family with two DR/DP recombinations (1996) (3)
Genetically Determined Strength of Natural Killer Cells is Enhanced by Adaptive HLA class I Admixture in East Asians (2020) (3)
Population-specific diversity of the immunoglobulin constant heavy G chain (IGHG) genes (2021) (3)
HLA alleles associated with relative rates of disease progression and different AIDS diagnosis in HIV-1 infected individuals (1992) (3)
111 HCV-specific cellular immune responses in subjects who are antiHCV-negative, HCV RNA-negative despite longterm (>15 years) injection drug use (2003) (3)
MicroRNA-29 stabilizes interferon-gamma mRNA by antagonizing AU-rich element-mediated decay (57.3) (2011) (3)
KIR and HLA-C: Immunogenetic regulation of human birth weight (2014) (3)
Selection Against Susceptibility to HIV-1 (1999) (3)
Faculty Opinions recommendation of Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. (2002) (3)
Multiple-Case Families Haplotypes Shared by Affected Members of Identification and Characterization of and Common Variable Immunodeficiency : in IgA Deficiency IGAD 1 Fine Mapping of (2000) (3)
Host Variation in Interferon, MHC Class I, Glycosylation, and Viral Transcription Genes Predict HIV Persistence (2021) (2)
Evidence for methylation as a regulatory mechanism in HLA-DR alpha gene expression. (1985) (2)
The Human Genes that Limit AIDS (2000) (2)
KIR gene allele frequencies in populations from USA (African American) USA (European) and England (2004) (2)
Genetic protection against HBV conferred by CCR5 Ä 32: evidence that CCR5 contributes to viral persistence (2006) (2)
Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015 (2016) (2)
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients (2022) (2)
Conversion of a melanoma cell line from an HLA class II positive to negative phenotype after treatment with anti-mycoplasma drugs. (1988) (2)
Identification of a novel TAP2 allele in a Colombian black population: gene conversion, ancestral intermediate or convergent change? (1997) (2)
Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis (2021) (2)
4-OR: Global diversity of KIR and HLA: Population-level evidence for co-evolution, natural selection, and signatures of demographic history (2007) (2)
Seeing the Unexpected (2012) (2)
Inhibitory KIR ligands are associated with higher P. falciparum parasite prevalence. (2020) (2)
Identification and Characterization of Antigen-Specific CD8+ T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing (2021) (1)
Consistent Effects of TSG 101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1 † (2018) (1)
Early immune adaptation in HIV-1 revealed by population-level approaches (2014) (1)
Advances in Brief Reduced Risk of AIDS Lymphoma in Individuals Heterozygous for the CCR 5D 32 Mutation 1 (1999) (1)
The human major histocompatibility complex and HIV-1 pathogenesis (1993) (1)
168-P: In silico resolution of ambiguous HLA typing data (2008) (1)
Recombinant structures expand and contract inter and intragenic diversification at the KIR locus (2013) (1)
OA011-05. TLR-mediated pDC responses to HIV-1 ligands (2009) (1)
Immune correlates of HIV-1 reservoir cell decline in early-treated infants (2022) (1)
ASSOCIATION OF HUMAN LEUKOCYTE ANTIGENS (HLA) WITH NASOPHARYNGEAL CARCINOMA (NPC) IN HIGH-RISK MULTIPLEX FAMILIES IN TAIWAN (2009) (1)
Impact of KIR and HLA Genotypes on Outcome in Nonmyeloablative Hematopoietic Cell Transplantation (HCT) Using HLA Matched Related Donors. (2006) (1)
Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection (2013) (1)
Frequent and strong antibody-mediated NK cell activation to HIV-1 Env in individuals with chronic HIV-1 infection (2012) (1)
Evaluation of the Association with Cervical Cancer of Polymorphisms in Syndecan-1, a Heparan Sulfate Proteoglycan Involved with Viral Cell Entry (2007) (1)
Do African and European ancestry and polymorphism of HLA class I play an important role in controlling HTLV-1 proviral load in admixed cohorts from Salvador, Brazil? (2014) (1)
MicroRNA-29 Stabilizes IFN-{gamma} mRNA by inhibiting GW182 (2012) (1)
Author response: HIV-1 DNA predicts disease progression and post-treatment virological control (2014) (1)
P032 Compound HLA/KIR genotypes influence risk of nasopharyngeal carcinoma in a Southern Chinese cohort (2015) (1)
Detection of Polymorphisms in the HIV-1 Coreceptor CCR5 Using Single-Strand Conformation Polymorphism. (1999) (1)
Stratified testing for HLA matching: Selection of identical sib pairs using microsatellite loci across HLA (1996) (1)
Alternative polyadenylation signals regulate HLA-A surface expression (2017) (1)
Human Leukocyte Antigen (HLA) Genotype and Risk of HIV Disease (2011) (1)
Parental-fetal interplay of immune genes leads to intrauterine growth restriction (2021) (1)
Differential expression of the HLA-DR genes in various melanoma cell lines treated with interferon-gamma: methylation of the HLA-DR alpha gene in these lines is not correlated with its expression. (1987) (1)
Characterization of the HLA-C*07:01:01G allele group in European and African-American cohorts. (2012) (1)
Reactive Human CD 8 T Cells that Recognize an Epitope Conserved between VZV , HSV and EBV (1)
Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection (2012) (1)
F5 The Principal Genetic Determinants for Nasopharyngeal Carcinoma in China Involve HLA Class I Antigen Recognition Groove (2012) (0)
HLA-A*03 is a Predictive Biomarker of Poor Response to Immune Checkpoint Blockade in Cancer (2021) (0)
Table 1, Known LILR, cellular distribution, and ligands (2003) (0)
Killer Cell Immunoglobulin-Like Receptors Are Associated with Common Variable Immune Deficiency (CVID) Pathogenesis (2016) (0)
High density mapping of the MHC reveals a common role for HLA- DRB1*01:03 in IBD and heterozygous advantage in ulcerative colitis (2014) (0)
Risk Factors for Ebola Virus Persistence in Semen of Survivors - Liberia. (2022) (0)
Figure 1, Map of the Leukocyte Receptor Complex (2003) (0)
Faculty Opinions recommendation of Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. (2006) (0)
Antiviral synergism (2005) (0)
P072 HLA types in ethnically diverse sub-saharan african populations (2019) (0)
Figure 7, Phylogenetic relationship of KIR gene sequences from four primate species (2003) (0)
Regulate Human Birth Weight HLA-C2 in Combination with Paternal KIR Maternal (2014) (0)
Author Correction: A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response (2021) (0)
Do African and European ancestry and polymorphism of HLA class I play an important role in controlling HTLV-1 proviral load in admixed cohorts from Salvador, Brazil? (2014) (0)
Faculty Opinions recommendation of HIV evolution: CTL escape mutation and reversion after transmission. (2004) (0)
Participants in HIV Study: Correction (1996) (0)
P660 - HLA associated with HTLV-I seroconversion after transfusion (1996) (0)
HIV‐1 Infection in Individuals With the CCR5‐&dgr;32/&dgr;32 Genotype: Acquisition of Syncytium‐Inducing Virus at Seroconversion (2002) (0)
Faculty Opinions recommendation of KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. (2002) (0)
Biomarker reveals HIV's hidden reservoir Determining the total amount of HIV DNA in people undergoing antiretroviral therapy could accelerate the development of novel therapies and potential cures for HIV infection. (2014) (0)
OR21 HLA-C downregulation by HIV adapts to host HLA genotype (2018) (0)
Faculty Opinions recommendation of Intense and highly localized gene conversion activity in human meiotic crossover hot spots. (2004) (0)
Concordance of Hla Haplotype Sharing and Aids/Cd4 Decline in Hemophilic Sibling Pairs: (1993) (0)
MicroRNA-29 Stabilizes IFN-γ mRNA by inhibiting GW182 (174.5) (2012) (0)
Molecular epidemiology : a practical approach (2001) (0)
Faculty Opinions recommendation of Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. (2001) (0)
Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral Therapy (cid:1) ‡ (2011) (0)
Mass spectrometric profiling of HLA-B44 peptidomes provides evidence for tapasin-mediated tryptophan editing (2023) (0)
Recognition of paternal trophoblast HLA-C by maternal uterine NK cell KIR determines the outcome of pregnancy (2011) (0)
Killer cell immunoglobulin – like receptor 3 DL 1 variation modifies HLA-B * 57 protection against HIV-1 Maureen (2018) (0)
Genetic association between HLA class I alleles and hepatitis B virus-related hepatocellular carcinoma in a southern Chinese population (2015) (0)
Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair (2013) (0)
HLA microsatellite analysis. (2003) (0)
th Meeting of the Irish Society of Human Genetics , Friday 2 nd (0)
Figure 8, Ribbon diagrams of KIR molecules (2003) (0)
Faculty Opinions recommendation of Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. (2002) (0)
Table 2, KIR gene names (2003) (0)
Patient-Specific Epitope 5 Repertoires Associated with HIV Control 6 7 Short Title : Epitope Repertoires Associated with HIV Control (2019) (0)
Figure 2, Domain structure of the KIR molecules (2003) (0)
Mapping recombination sites by defining and genotyping polymorphic regions in the HLA class II region (1994) (0)
KIR-HLA footprints and NK cell-mediated recognition of HIV-1 (2012) (0)
Multigenic and Overlapping Susceptibilities between IDDM and Cystic Fibrosis Complicated with Diabetes (CF/DM) 397 (1997) (0)
3 POPULATIONAL ANALYSIS REVEALS A LINK BETWEEN COMPLEX VIRAL ESCAPE FROM CD8+ T-CELL RESPONSES AND PROTECTION IN HCV INFECTION (2011) (0)
Erratum: Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells (Science DOI: 10.1126/science.aam8825) (2019) (0)
Determination of polymorphism in DMB (1992) (0)
Liebensteiner of Biotic and Abiotic Reactions Archaeal ( Per ) Chlorate Reduction at High Temperature : An Interplay (2014) (0)
HLA-C Alleles Genes in the Absence of Specific Receptor Killer Ig-Like Arthritis : Influence of Activating Cutting Edge : Susceptibility to Psoriatic (2002) (0)
Detection of recombination within the HLA complex by mapping and typing dinucleotide repeats (1994) (0)
Erratum to: Distribution of killer cell immunoglobulin-like receptors(KIR) and their HLA-C ligands in two Iranian populations (2010) (0)
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles (2017) (0)
Unequal Crossing Over Locus by KIR Cutting Edge: Expansion of the (2003) (0)
Genetic susceptibility factors in familial nasopharyngeal carcinoma (2016) (0)
Table 3, KIR ligand specificity (2003) (0)
Oral presentation Abstract session 7Selected HLA class I and TAP alleles confer relative rates of disease progression in HIV-1 infected individuals (1994) (0)
The evolution of variation at the killer cell immunoglobulin like receptor gene complex of human disease (2009) (0)
314 NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer (2021) (0)
The Role of Human Genetics in HIV-1 Infection (2019) (0)
Functional impact of a cellular Long non-coding RNA on CCR5 expression and HIV infection (2019) (0)
84-P: Unusual KIR haplotypes in patients with psoriatic arthritis and their family members (2007) (0)
83-P: Allelic Diversity of KIR2DL4 and KIR3DL2 in the Population of Curitiba, Brazil (2010) (0)
Class-I Proteins in Normal and HIV-Infected Relative Expression Levels of the HLA (2015) (0)
Functional evidence supporting the predicted role of KIR3DS1 in the host response to HIV: KIR3DS1 is an activating receptor expressed by human Natural Killer cells (52.5) (2007) (0)
HLA-DQA and DQB allele frequencies in cystic fibrosis patients with insulin-dependent diabetes (IDDM) (1991) (0)
Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome (2019) (0)
The Identification of Genes for Complex Genetic Diseases (2000) (0)
Figure 6, KIR genotype profiles observed to date (2003) (0)
Regulation of HLA class II gene expression by phorbol 12,13-dibutyrate (1988) (0)
MoleculesDistinct Assembly Profiles of HLA-B (2014) (0)
Host genetic variation and HIV disease: from mapping to mechanism (2017) (0)
Figure 5, Distinct KIR haplotypes based on gene content (2003) (0)
Faculty Opinions recommendation of Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. (2002) (0)
Faculty Opinions recommendation of Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. (2003) (0)
Progression to AIDS Associated with Opposite Patterns of New Class I and II HLA Alleles Strongly (1999) (0)
TAP gene polymorphism in healthy controls and patients with rheumatoid arthritis in Koreans (1994) (0)
P069UTR SNPS rs111686073 and rs73410010 independently modify expression of tapasin in blacks (2018) (0)
LBOR03: ASSOCIATION BETWEEN CTL PRECURSOR FREQUENCY TO HLA-C MISMATCHES AND HLA-C ANTIGEN CELL SURFACE EXPRESSION (2015) (0)
Figure 3, Exon-intron structure the KIR genes (2003) (0)
PP122—Regulation of human leukocyte antigen expression and nevirapine-induced adverse drug reactions in a malawian hiv-positive population (2013) (0)
This information is current as Disease Related to HIV Infection and Tuberculosis II Tetramers Reveals Phenotypic Differences Specific Cells Using MHC Class − tuberculosis Mycobacterium Characterization of (2017) (0)
Faculty Opinions recommendation of Impairment of NK cell function by NKG2D modulation in NOD mice. (2003) (0)
KIR Locus Variation (2014) (0)
Disequilibrium with HLA-B*5703 Viremia Is Independent of Its Linkage Mediated Control of HIV - HLA-A*7401 (2011) (0)
Mapping recombination sites in the HLA class II region (1996) (0)
Genetic protection against HBV conferred by CCR5Ä32: evidence that CCR5 (2006) (0)
MoleculesAssembly Profiles of HLA-B (2014) (0)
Figure 4, Gene order of two fully sequenced KIR haplotypes (2003) (0)
Hematopoietic Stem Cells Joint Report (2006) (0)
MHC Locus Variation (2015) (0)
HLA : human leukocyte antigen KIR : killer cell immunoglobulin-like receptor HIV : human immunodeficiency virus GWAS : genome-wide association study SIV : simian immunodeficiency virus (2013) (0)
Relationship between human leukocyte antigen alleles and risk of Kaposi’s sarcoma in Cameroon (2019) (0)
Localization of the recombination points in a family with two DR/DP recombinations. (1996) (0)
HLA Architecture of HIV Disease Pathogenesis (2010) (0)
A mutation in KIR3DS1 that results in truncation and lack of cell surface expression (2007) (0)
Psoriatic Arthritis and Killer Ig-Like Receptor Combinations in Protection / Susceptibility Conferred by HLA Autoimmune Disease : Hierarchy of Cutting Edge : Heterozygote Advantage in (2004) (0)
Sequence-specific priming as a rapid screen for known mutations. (1999) (0)
Genetically Determined Strength of Natural Killer Cells is Enhanced by Adaptive Admixture of HLA class I Allotypes in East <a>Asians</a> (2021) (0)
Distinct viral reservoirs in individuals with spontaneous control of HIV-1 (2020) (0)
P052 A novel algorithm for KIR copy number imputation by KIBAG and consolidation of population specific KIR references in HKimpNet (HLA & KIR imputation network) (2019) (0)
Peptidome Diversities of human leukocyte antigen (HLA-B) allotypes (2017) (0)
Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia (2022) (0)
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes (2021) (0)
Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. (2022) (0)
The Major Histocompatibility Complex Class II Alleles Mamu - DRB1 * 1003 and -DRB1 * 0306 Are Enriched in a Cohort of Simian Immunodeﬁciency Virus-Infected Rhesus Macaque Elite Controllers (cid:1) (2007) (0)
Abstract 2160: Immune escape mutations in HLA Class I,B2MandCASP8genes shape tumor evolution (2020) (0)
KIR/HLA Compound Genotypes Determine Early Antiviral Response of Natural Killer Cells (35.17) (2007) (0)
HIV post-treatment controllers have distinct immunological and virological features. (2023) (0)
Host variation in type I interferon signaling genes (MX1), CCR5Δ32, and MHC class I alleles in treated HIV+ non-controllers predict viral reservoir size (2022) (0)
Risk Factors for Persistent Ebola Virus Infection in Semen Among Survivors From Liberia (2021) (0)
Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner (2022) (0)
A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44 (2019) (0)
Single Nucleotide Polymorphism in langerin Associates with Heterosexual HIV-1 Transmission (2012) (0)
CWRU CFAR 2012 Annual Conference: AIDS Pathogenesis, Prevention and Cure (2012) (0)
CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome (2019) (0)
Viral and Host Mediators of Non-Suppressible HIV-1 Viremia (2023) (0)
Associations of alleles atloci located throughout the HLA complex (1996) (0)
Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade (2022) (0)
Disequilibrium patterns of the peptide transporter loci within the HLA class II region (1994) (0)
Faculty Opinions recommendation of Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. (2002) (0)
NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer (2022) (0)
124 NK cells: friends or foes? (2009) (0)
Evidence for chromatin structure as a regulatory determinant in HLA-DR alpha gene expression. (1985) (0)
Erratum: A mutation in KIR3DS1 that results in truncation and lack of cell surface expression (Immunogenetics DOI: 10.1007/s00251-007-0240-8) (2007) (0)
Abstract 1836: Combining a novel retinoic acid receptor-γ agonist with immune checkpoint blockade represses lung cancer growth in vivo (2023) (0)
Determination of PSF alleles and haplotypes (1992) (0)
Host variation in type I interferon signaling genes (MX1), C–C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size (2022) (0)
O647 - Combinations of MHC genes influence HIV-1 disease course (1996) (0)
Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression (2023) (0)
Hepatitis C virus hijacks host microRNAs to dampen antiviral interferon signaling (2016) (0)
variation differentially regulates influencing HIV disease outcome. (2019) (0)
Differential immunodominance hierarchy of CD 8 + T-cell responses in HLA-B * 27 (2018) (0)
Human Immunodeﬁciency Virus Type 1-Speciﬁc CD8 (cid:1) T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4 (cid:1) T Cells (cid:1) † (2009) (0)

This paper list is powered by the following services:

Other Resources About Mary Carrington

en.wikipedia.org

What Schools Are Affiliated With Mary Carrington?

Mary Carrington is affiliated with the following schools: